Document is current
Any future updates will be listed below
-
Authors
Ruiz García, Yara https://orcid.org/0000-0003-4040-6139
Sohn, Woo-Yun
Seib, Kate L. https://orcid.org/0000-0002-7094-3528
Taha, Muhamed-Kheir
Vázquez, Julio A.
de Lemos, Ana Paula S.
Vadivelu, Kumaran
Pizza, Mariagrazia
Rappuoli, Rino https://orcid.org/0000-0002-8827-254X
Bekkat-Berkani, Rafik
- License Information
-
More Information
Article History
Received: 5 May 2021
Accepted: 1 October 2021
First Online: 29 October 2021
Competing interests
: Y.R.G., R.B.-B., R.R., W.-Y.S., K.V., and M.P. are employed by the GSK group of companies and declare financial and non-financial conflicts of interest. R.B.-B., R.R., W.-Y.S., K.V., and M.P. also hold shares in the GSK group of companies. J.A.V. performs contract work for the Institute of Health Carlos III funded by GSK and Pfizer and has received personal fees from GSK, Pfizer, and Sanofi Pasteur. J.A.V. has no non-financial conflicts of interest to declare. M.-K.T. reports grants from GSK and Pfizer during the conduct of the study, grants from Sanofi outside the submitted work, and he also has a patent issued (630133). K.L.S. reports a grant from the National Health and Medical Research Council outside the submitted work. Other authors have no financial or non-financial conflicts of interest to declare.
